- No public price.
- Not disclosed
- Not disclosed
- —
- —
- DK
Radiology
Cerebriu
by Cerebriu A/S · DK
Apollo AI for brain MRI that flags infarcts, intracranial hemorrhage and tumors during the scan, CE-marked Class IIa and not cleared in the US.
On this page
15/100
Not rated: too little independent evidence yet.
- Regulatory & Compliance0/28
No FDA clearance listed
- Clinical Integration0/6.6
No EHR integrations listed
- Evidence Strength7.3/26
1 peer-reviewed paper
- Vendor & Market3/18
Seed-stage or unfunded
- Sentiment & Transparency2.5/5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/18
No FDA clearance listed
- HIPAA / SOC2 / BAA0/10
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/4
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/2
None of the top-3 EHRs covered
- Peer-reviewed papers7/18
1 peer-reviewed paper
- RCT / meta-analysis / systematic review0/8
No RCT, meta-analysis, or systematic review
- Funding & adoption signal3/12
Seed-stage or unfunded
- Years in market0/6
Founded year not recorded
- Pricing transparency3/5
Pricing on request, no public amounts
Apollo AI for brain MRI that flags infarcts, intracranial hemorrhage and tumors during the scan, CE-marked Class IIa and not cleared in the US.
No public price.
Evidence record
No FDA decision cited in our research as of November 2, 2026.
1 study on PubMed: 1 other, published 2023. Read the literature summary
- Score computed November 2, 2026, method 1.2.0
- Review written November 2, 2026
MedAI Verdict, Cerebriu record, https://medaiverdict.com/tools/cerebriu, version November 2, 2026
Bottom line
Apollo, from Cerebriu A/S in Copenhagen, is brain MRI software that the company says is CE-marked Class IIa and deployed across Europe and the Middle East. It is not cleared in the US, and the company's footer reads "For investigation use only in the US." The footer adds that Apollo is regulated as a medical device in the EU under Directive 93/42/EEC and is covered by the transitional provision in MDR 2017/745 Article 120. It fits a European stroke or neuroradiology service that wants findings flagged while the patient is still in the scanner. A US buyer who needs a cleared product is outside what the company offers today.
What does Apollo do in the scanner?
Cerebriu's modules are Apollo Acquire, which works during the scan, and Apollo Interpret. For Acquire, the site says the protocol is "adapted to what the scan finds, in one click," with intracranial hemorrhage flagged during acquisition and infarcts and tumors detected at acquisition. Interpret is described as giving each case an urgency level and ranking the worklist by clinical urgency across scanners and sites. A Smart Protocol for Siemens Healthineers MRI is also offered, along with an OEM partner offering. The version named on the site is Apollo 2.1.2.
What evidence backs Apollo?
The one performance figure is infarct detection reaching 90.1% sensitivity at an early stage, from a conference contribution cited on the home page. The publications page lists nine items and mostly does not say who ran each study. One is a Nature Communications Medicine paper on SmartGAD, an Apollo module for selective gadolinium use, which is probably vendor-involved. Another is a 2024 Diagnostics paper on automatic DWI/FLAIR mismatch assessment in stroke. PMID 38913106 is a systematic review and meta-analysis of AI for MRI stroke detection across several tools, and it is not Apollo-specific. A European Journal of Radiology study tested a commercially available deep learning algorithm for ischemic lesions on brain MRI in 995 patients, with no statement of which algorithm. Two MDPI systematic reviews and a Copenhagen segmentation paper are background.
What does the site say about integration and support?
The site says Apollo works "across scanners and sites" and names no PACS or worklist vendor. Compliance material on the site is a privacy policy and a code of ethics, with no ISO, HIPAA, SOC 2 or GDPR certificate shown. Support runs through a Jira Service Desk portal. No price is public, and the route in is a demo request.
The verdict
A European service weighing Apollo has a CE mark, a Siemens-specific Smart Protocol and one early sensitivity figure to go on. For a US hospital the answer is fixed by the company's own wording, since US use is investigational.
Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. |
Source: vendor pricing page. Last checked November 2, 2026.
What deploys cleanly
Carries CE per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.
What the literature says
1 peer-reviewed study indexed on PubMed evaluate Cerebriu in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.
- Diagnostic test accuracy study of a commercially available deep learning algorithm for ischemic lesion detection on brain MRIs in suspected stroke patients from a non-comprehensive stroke center. (opens in new tab)
- Krag CH, Müller FC, Gandrup KL, et al.· Eur J Radiol· 2023
- To estimate the ability of a commercially available artificial intelligence (AI) tool to detect acute brain ischemia on Magnetic Resonance Imaging (MRI), compared to an experienced neuroradiologist. We retrospectively included 1030 patients with brain MRI, suspected of stroke from January 6th, 2020 to 1st of April 2022, based on these criteria: Age ≥ 18 years, symptoms within four weeks before the scan. The neuroradiologist reinterpreted the MRI scans and subclassified ischemic lesions for reference. We excluded scans with interpretation difficulties due to artifacts or…
Other radiology
See the full radiology ranking
Siemens Healthineers AI-Rad Companion
by Siemens Healthineers
AI-Rad Companion: Chest CT, Chest X-ray, Brain MR, Prostate MR and Organs RT (radiotherapy contouring) modules, delivered through teamplay.
No public price on the vendor page.|FDA 510(k) (multiple) / CE Mark (MDD/MDR. MDR status not verified)
GE HealthCare AI Suite
by GE HealthCare
Portfolio of separately cleared AI-enabled GE HealthCare devices and software, including AIR Recon DL, Sonic DL, Critical Care Suite, Caption AI and icobrain.
No public price. Products are sold with scanners or as scanner options, on enterprise quotes.|FDA 510(k) (multiple)
Aidoc
by Aidoc
Clinical AI platform (aiOS) with FDA-cleared triage, notification and quantification algorithms for radiology and neurovascular care.
Private offer only. No trial is stated.|FDA 510(k) (multiple) / EU MDR 2017/745
Viz.ai
by Viz.ai
Care coordination platform with FDA-cleared imaging AI for stroke, vascular and cardiac conditions.
No public price. Sold to health systems after a demo request.|FDA 510(k) (multiple) / FDA De Novo (ContaCT, Viz HCM)